134 related articles for article (PubMed ID: 11278630)
21. Voltage-dependent acceleration of Ca(v)1.2 channel current decay by (+)- and (-)-isradipine.
Berjukow S; Hering S
Br J Pharmacol; 2001 Aug; 133(7):959-66. PubMed ID: 11487504
[TBL] [Abstract][Full Text] [Related]
22. Identification of inactivation determinants in the domain IIS6 region of high voltage-activated calcium channels.
Stotz SC; Zamponi GW
J Biol Chem; 2001 Aug; 276(35):33001-10. PubMed ID: 11402052
[TBL] [Abstract][Full Text] [Related]
23. Molecular determinants of diltiazem block in domains IIIS6 and IVS6 of L-type Ca(2+) channels.
Hockerman GH; Dilmac N; Scheuer T; Catterall WA
Mol Pharmacol; 2000 Dec; 58(6):1264-70. PubMed ID: 11093762
[TBL] [Abstract][Full Text] [Related]
24. Distinct properties of amlodipine and nicardipine block of the voltage-dependent Ca2+ channels Cav1.2 and Cav2.1 and the mutant channels Cav1.2/dihydropyridine insensitive and Cav2.1/dihydropyridine sensitive.
Lin M; Aladejebi O; Hockerman GH
Eur J Pharmacol; 2011 Nov; 670(1):105-13. PubMed ID: 21910984
[TBL] [Abstract][Full Text] [Related]
25. A region of N-type Ca(2+) channel critical for blockade by the dihydropyridine amlodipine.
Miyashita Y; Furukawa T; Kamegaya E; Yoshii M; Nukada T
Eur J Pharmacol; 2010 Apr; 632(1-3):14-22. PubMed ID: 20097194
[TBL] [Abstract][Full Text] [Related]
26. Molecular mechanism of calcium channel block by isradipine. Role of a drug-induced inactivated channel conformation.
Berjukow S; Marksteiner R; Gapp F; Sinnegger MJ; Hering S
J Biol Chem; 2000 Jul; 275(29):22114-20. PubMed ID: 10766758
[TBL] [Abstract][Full Text] [Related]
27. Allosteric interactions required for high-affinity binding of dihydropyridine antagonists to Ca(V)1.1 Channels are modulated by calcium in the pore.
Peterson BZ; Catterall WA
Mol Pharmacol; 2006 Aug; 70(2):667-75. PubMed ID: 16675661
[TBL] [Abstract][Full Text] [Related]
28. Differential blocking action of dihydropyridine Ca2+ antagonists on a T-type Ca2+ channel (alpha1G) expressed in Xenopus oocytes.
Furukawa T; Nukada T; Miura R; Ooga K; Honda M; Watanabe S; Koganesawa S; Isshiki T
J Cardiovasc Pharmacol; 2005 Mar; 45(3):241-6. PubMed ID: 15725949
[TBL] [Abstract][Full Text] [Related]
29. Ca2+-sensitive inactivation and facilitation of L-type Ca2+ channels both depend on specific amino acid residues in a consensus calmodulin-binding motif in the(alpha)1C subunit.
Zühlke RD; Pitt GS; Tsien RW; Reuter H
J Biol Chem; 2000 Jul; 275(28):21121-9. PubMed ID: 10779517
[TBL] [Abstract][Full Text] [Related]
30. Different voltage-dependent inhibition by dihydropyridines of human Ca2+ channel splice variants.
Soldatov NM; Bouron A; Reuter H
J Biol Chem; 1995 May; 270(18):10540-3. PubMed ID: 7737988
[TBL] [Abstract][Full Text] [Related]
31. Meiosis reinitiation of mussel oocytes involves L-type voltage-gated calcium channel.
Tomkowiak M; Guerrier P; Krantic S
J Cell Biochem; 1997 Jan; 64(1):152-60. PubMed ID: 9015763
[TBL] [Abstract][Full Text] [Related]
32. Inactivation determinant in the I-II loop of the Ca2+ channel alpha1-subunit and beta-subunit interaction affect sensitivity for the phenylalkylamine (-)gallopamil.
Sokolov S; Weiss RG; Kurka B; Gapp F; Hering S
J Physiol; 1999 Sep; 519 Pt 2(Pt 2):315-22. PubMed ID: 10457051
[TBL] [Abstract][Full Text] [Related]
33. Calcium binding in the pore of L-type calcium channels modulates high affinity dihydropyridine binding.
Peterson BZ; Catterall WA
J Biol Chem; 1995 Aug; 270(31):18201-4. PubMed ID: 7629136
[TBL] [Abstract][Full Text] [Related]
34. Molecular mechanism of diltiazem interaction with L-type Ca2+ channels.
Kraus RL; Hering S; Grabner M; Ostler D; Striessnig J
J Biol Chem; 1998 Oct; 273(42):27205-12. PubMed ID: 9765241
[TBL] [Abstract][Full Text] [Related]
35. Glutamate substitution in repeat IV alters divalent and monovalent cation permeation in the heart Ca2+ channel.
Parent L; Gopalakrishnan M
Biophys J; 1995 Nov; 69(5):1801-13. PubMed ID: 8580323
[TBL] [Abstract][Full Text] [Related]
36. Homology model of dihydropyridine receptor: implications for L-type Ca(2+) channel modulation by agonists and antagonists.
Zhorov BS; Folkman EV; Ananthanarayanan VS
Arch Biochem Biophys; 2001 Sep; 393(1):22-41. PubMed ID: 11516158
[TBL] [Abstract][Full Text] [Related]
37. Mutations in the EF-hand motif impair the inactivation of barium currents of the cardiac alpha1C channel.
Bernatchez G; Talwar D; Parent L
Biophys J; 1998 Oct; 75(4):1727-39. PubMed ID: 9746514
[TBL] [Abstract][Full Text] [Related]
38. Molecular modeling of interactions of dihydropyridines and phenylalkylamines with the inner pore of the L-type Ca2+ channel.
Lipkind GM; Fozzard HA
Mol Pharmacol; 2003 Mar; 63(3):499-511. PubMed ID: 12606756
[TBL] [Abstract][Full Text] [Related]
39. DHP-insensitive L-type-like Ca channel of ascidian acquires sensitivity to DHP with single amino acid change in domain III P-region.
Izumi-Nakaseko H; Yamaguchi S; Ohtsuka Y; Ebihara T; Adachi-Akahane S; Okamura Y
FEBS Lett; 2003 Aug; 549(1-3):67-71. PubMed ID: 12914927
[TBL] [Abstract][Full Text] [Related]
40. Parathyroid cells express dihydropyridine-sensitive cation currents and L-type calcium channel subunits.
Chang W; Pratt SA; Chen TH; Tu CL; Mikala G; Schwartz A; Shoback D
Am J Physiol Endocrinol Metab; 2001 Jul; 281(1):E180-9. PubMed ID: 11404236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
